Naveen Pemmaraju shared a post on X:
“Superb clinic and research teams working together in Team Pemm clinic.
Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, and Myeloproliferative Neoplasms this month!
From left to right: Naveen Pemmaraju, Michelle Golez, Terri Saenz, Rhona Pinsoy, Dr. Mir Lim, Dr. Kekejian, Rodney Haltom.”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.